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Decision makingTechnologies for automated detection of neonatal seizures are gradually moving towards cot-side implementa-
tion. The aim of this paper is to present different ways to visualize the output of a neonatal seizure detection sys-
tem and analyse their inﬂuence on performance in a clinical environment. Three different ways to visualize the
detector output are considered: a binary output, a probabilistic trace, and a spatio-temporal colormap of seizure
observability. As an alternative to visual aids, audiﬁed neonatal EEG is also considered. Additionally, a survey on
the usefulness and accuracy of the presented methods has been performed among clinical personnel. The main
advantages and disadvantages of the presented methods are discussed. The connection between information vi-
sualization and differentmethods to compute conventional metrics is established. The results of the visualization
methods along with the system validation results indicate that the developed neonatal seizure detector with its
current level of performance would unambiguously be of beneﬁt to clinicians as a decision support system. The
results of the survey suggest that a suitableway to visualize the output of neonatal seizure detection systems in a
clinical environment is a combination of a binary output and a probabilistic trace. Themain healthcare beneﬁts of
the tool are outlined. The decision support systemwith the chosen visualization interface is currently undergoing
pre-market Europeanmulti-centre clinical investigation to support its regulatory approval and clinical adoption.
© 2014 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).1. Introduction
Neonatal seizures are the most common neurological emergency
in the neonate and are a serious concern for clinicians and parents
worldwide [1]. Only about one third of all neonatal seizures are clin-
ically visible [2] and many remain undetected in the busy Neonatal
Intensive Care Unit (NICU) environment. The only method available
to detect all neonatal seizures accurately is continuous multi-
channel EEG monitoring. Interpretation of neonatal EEG requires a
neurophysiologist or paediatric neurologist with speciﬁc expertise
in neonatal EEG. This expertise is not available on a 24 h basis,
7 days a week [3]. To ﬁll the gap in the lack of availability of experts,
clinical staff in the NICU are using a simpler form of EEG monitoring,
called amplitude integrated EEG or aEEG [4]. Amplitude integrated
EEG is a logarithmically-scaled, temporally-smoothed and com-
pressed display of EEG which is usually computed from two EEG
channels, one from each hemisphere. Despite the fact that many
short and focal neonatal seizures are undetectable with aEEG and
interobserver agreement is poor [5], aEEG currently serves as a
trade-off between very inaccurate clinical detection of seizures ande@ucc.ie (W. Marnane),
ody).
. This is an open access article undervery accurate but scarcely available neurophysiologic expertise,
and thus is widely adopted worldwide in the NICU [3].
As an alternative to aEEG usage, many groups in theworld arework-
ing to develop algorithms for automated detection of neonatal seizures
on continuous multi-channel EEG. An automated decision support
system (DSS) that could detect and annotate seizures on the neonatal
EEGwould be extremely useful for clinicians in theNICU [44]. A number
of methods have been previously proposed but to date their transition
to clinical use has been limited due to: (i) the proof of concept nature
of the work performed, which involved carefully selected short-
duration EEG segments [6–9]; (ii) an unrealistic validation regime
such as testing on training data or excluding the worst performing
records [10–12]; and (iii) the provision of algorithm performance
which is currently unacceptable in a clinical setting [13–17].
There are two key directions in automated neonatal seizure detec-
tion. The ﬁrst follows analytical learning principles [18] and focuses on
the creation of a set of heuristic rules and thresholds from clinical
prior knowledge [6–8,10,12–15]. The resultant detectors analyse EEG
using a small number of the descriptors from which a decision is
made using empirically derived thresholds. Binary decisions are obtain-
edwith this approach. The second approach relies on inductive learning
[18] and utilizes model-based parameterization [9,16] or statistical
classiﬁer basedmethods [11,19,20], which employ elements ofmachine
learning to classify a set of features using a data-driven decision rule.the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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decisions such as probability of seizure.
Our grouphas recently developed [19,21], validated [20] and patented
[22] an accurate and robust real-time neonatal seizure detection system
combining both of these approaches. In order to have the system used
at the cot-side, as well as to help achieve regulatory approval, we need
to identify the most intuitive and synergetic way to convey the system
output information to neonatal caregivers. In this context, when the de-
veloped technology approaches cot-side implementation, it becomes im-
portant to build a viable interface between the new engineering
component and establishedmedical environments [23–25]. TheNICU en-
vironment (Fig. 1) already has plenty of technologies, including a number
of physiological monitors; adding yet another ‘technology’ becomes a
challenging task.
In this study, we propose and examine 3 different ways to visualize
the output of an automated neonatal seizure detector: a binary output, a
probabilistic output and a spatio-temporal colormap output. Addition-
ally, the algorithm-driven audiﬁcation of neonatal EEG is also explored
as an alternative to a visual output. Five neonatologists with experience
in interpreting the cotside EEG from the second largestmaternity hospi-
tal in Europe (Cork University Maternity Hospital) were surveyed over
approximately 1 h, answering over 100 questions, and the survey
results are also reported in this work.
The paper is organized as follows: Section 2 brieﬂy describes the
neonatal seizure detection systemdeveloped by the group. Section 3 de-
scribes 3 different ways to visualize the system output information
along with audiﬁcation of neonatal EEG. A link between the ways that
the metrics are computed and the system output is visualized are
established in Section 4. Section 5 presents and discusses the survey
results. Section 6 introduces the chosen interface for the developed
DSS which is currently undergoing pre-market European multi-centre
clinical investigation to support its regulatory approval and clinical
adoption. Section 7 links the study to the theory of DSS. Economic
beneﬁts of the developed technology are outlined in Section 8. Our
expectations from the results of the clinical trial are given in Section 9.
Conclusions are drawn in Section 10.
2. Neonatal seizure detector
Thedeveloped automatedneonatal seizure detection system is shown
in Fig. 2. A video EEG machine was used to record multi-channel EEG
using the 10–20 system of electrode placement modiﬁed for neonates.
The following 8 EEG channels in bipolar pairs are used to feed the EEG
data into the system: F4–C4, C4–O2, F3–C3, C3–O1, T4–C4, C4–Cz,
Cz–C3 and C3–T3. It has been shown that frequencies of neonatal EEG
seizures range between 0.5 and 13 Hz and the dominant frequencies of
seizures vary between 0.5 and 6 Hz [26]. The EEG from the 8 channelsFig. 1. Clinical environment in NICU with EEG monitoring system on the right.is downsampled to 32 Hz with an anti-aliasing ﬁlter set at 12.8 Hz. The
EEG is then split into 8 s epochs with 50% overlap between epochs. The
most recent recommendations by the International Federation of Clinical
Neurophysiology [27] suggest that 5 s is the minimum seizure duration
if the background EEG is normal and 10 s if the background EEG is abnor-
mal. A window length of 8 s was chosen given that hypoxic ischemic en-
cephalopathy (HIE) is the commonest cause of seizure in the full term
neonate and the background EEG is always abnormal in those with sei-
zures. This window length would also prevent short duration seizure-
like events (e.g. brief intermittent rhythmic discharges) being
incorrectly detected as seizure events. A long feature vector which
consists of ﬁfty-ﬁve features is extracted from each epoch. The features
are designed to convey both time and frequency domain characteristics
as well as information theory based parameters.
A Support Vector Machine (SVM) classiﬁer is trained on data which
are normalized anisotropically by subtracting themean and dividing by
the standard deviation to assure commensurability of the various
features. This normalizing template is then applied to the testing data.
The obtained classiﬁer is applied separately to each channel of the test-
ing data as neonatal seizures can be localized to a single EEG channel.
The output of the SVM is converted to probability-like values with a
sigmoid function [28]. The probabilistic output is then time-wise
smoothed with a moving average ﬁlter. Detailed information on the
system can be found in [19].
Several important enhancements of the developed system have
recently been investigated. A wider feature set which included spectral
slope features from speech recognition has been examined in [29]. A
Gaussian mixture model classiﬁer has been developed in [30] and
contrasted to SVM with the classiﬁer combination performed in [31].
Adaptive spatial weighting of EEG channels based on the statistics of
spatial neonatal seizure distributions has been introduced in [32].
Similarly, temporal weighting of the probabilistic output of the
classiﬁer based on the statistically most likely locations of neonatal
seizures since the time of birth has been introduced in [21]. The
short term seizure event context has been shown to increase the
robustness of the detector to the seizure-like artefacts, in particular
the respiration artefact [33].
The developed system has been validated in [20,21,33] using leave-
one-patient-out (LOO) cross validation which is known to provide the
least biased assessment of performance. This was achieved using a
large clinical dataset, comprising long unedited multi-channel EEG
recordings from 18 neonates with seizures and 20 neonates without
seizures, totalling 1479 h of multi-channel EEG in duration and with
1389 seizures. Subsequently, the system was independently validated
in [34] on a separate dataset of 41 neonates (full-term HIE, 7 with sei-
zures, 377 seizures) and, more recently in [33], on a larger randomised
dataset comprising 51 full-term neonates with HIE (24 with seizures,
1142 seizures, totalling 2540 h of multi-channel in duration). In both
cases, retrospectively with LOO cross validation and using prospective
datasets, similar levels of performance were achieved as measured by
the mean area under the receiver operating characteristics curve
(AUC) with 95.4% in [34], 96.1% in [33] and 96.7% in [21].
The system is currently undergoing a pre-market European multi-
centre clinical investigation. The chosen way to visualize the system
output in a clinical environment should maximise the synergy between
the existing clinical practice and the support provided by the developed
tool.
It is possible to see from Fig. 2 that the system can output multiple
probabilistic traces, one per each channel. The maximum of the aver-
aged probabilities across all channels can be computed to represent
the ﬁnal support of a seizure resulting in a single overall probabilistic
trace. This probabilistic trace can be compared with a threshold to pro-
duce a trace of binary decisions: 1 for seizure and 0 for non-seizure. The
‘collar’ technique is applied last — every seizure decision is extended
from either side to account for the delay introduced by the moving av-
erage smoothing and to compensate for possible difﬁculties in detecting
Fig. 2. Neonatal seizure detection system diagram.
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output. In the next section, the main advantages and disadvantages of
these representations will be discussed.
3. Visualization methods
3.1. Amplitude-integrated EEG
The amplitude-integrated EEG is widely used in NICUs. There have
been numerous studies that report low sensitivity of this tool for neona-
tal seizure detection and its inappropriateness for use in the neonatal(a)
(b)
(c)
(d)
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Fig. 3. Example of visualization of the output of the neonatal seizure detection system for 66m
(c) — probabilistic output, and plot (d) — spatio-temporal map. Seizure onset and offset are anpopulation in general [5,42]. Technically, the ﬁltered EEG signal is ﬁrst
rectiﬁed i.e. negative voltages are converted to positive values. The am-
plitudes are then smoothed using a moving average ﬁlter and the ﬁnal
result is plotted on a semi-logarithmic scale which is linear from 0 to
10 μV, and logarithmic from 10 to 100 μV. The aEEG emphasises the am-
plitude of the EEG signal [35]. Interpretation of aEEG is primarily based
on pattern recognition and experience of the user is important. The
maximum and minimum peak-to-peak amplitudes of the EEG signal
are displayed to indicate the variance in aEEG amplitudes. Typically,
an increase in the lower border of the aEEG trace is representative of sei-
zures as shown in Fig. 3(a).Time, in minutes
of EEG. Plot (a) indicates aEEG channels, plot (b)— binary output at a threshold of 0.7, plot
notated as 16 min 37 s–30 min 05 s. Best viewed in colour.
EEG
Filtering
[0.5-13Hz]
Downsampling
[32Hz]
Phase vocoder
[100 slower]
Frequency mapping
[1000 quicker]
256samples x 1000s 32samples x 1000s
32samples x 100000s
Audio
channel
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Automated seizure 
detection system gain 
control
32000samples x 100s
Fig. 4. A ﬂowchart for audiﬁcation of 1000 s of neonatal EEG.
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The binary output as shown Fig. 3(b) is the simplest way to convey
system output information to neonatal healthcare professionals. It dis-
plays 1 when there is a seizure according to the automated system
and 0 when there is none and corresponds to the ‘binary decision’ in
Fig. 2. As mentioned in the introduction, most reported systems that
are based on a set of rules and thresholds are explicitly designed to pro-
vide the binary output. At the same time, the binary output can also be
obtained from the systems that provide the continuous probabilistic
output. The binary output is intuitive and there is no need in training
for interpretation.
The need for a chosen threshold is a clear disadvantage. The threshold
on its own does not result in bad or good performance; it is a point on the
performance curve which merely deﬁnes a trade-off between the two
competing metrics — the rate of correctly detected seizures and the rate
of false alarms. For the task of neonatal seizure detection, many variables
such as themedical/economic/social costs/risks of being falsely treated as
a seizure patient or being falsely considered as a non-seizure patientmust
be incorporated to ﬁnd an optimal threshold. The optimal threshold is a
slope on the operating curve and ﬁnding it is a difﬁcult task in its own
right [36]. Similarly, the binary form does not contribute any conﬁdence
to the decision making process. It is thus not possible to derive how
much in excess of the chosen threshold the system output was.
3.3. Probabilistic output
The problem of decision conﬁdence can be addressed by visualizing
the probability trace instead of the binary output, as seen in Fig. 3(c).
The probability rises when seizure activity is suspected in the EEG.
Thus, the probabilistic trace provides a measure of the conﬁdence of
the decision. With the probabilistic output, an additional temporal con-
text dimension is introduced into the decisionmaking— it is possible to
perceive the level of increase of the current probabilistic activity over
the past probabilistic activity. The probabilistic system output corre-
sponds to ‘Final probability’ in Fig. 2.
Although it seems to make sense at ﬁrst to provide this information
to a neonatal health care professional, one might argue that the disad-
vantage of the probabilistic method is that the healthcare professional
will have to look at all of the suggested possible seizures, even those
with low conﬁdence. Thus, the system can only support a decision
that is already made. In contrast, if the physician decides not to look at
seizures with lower than, say, 70% conﬁdence rating, then a threshold
has just been chosen similarly to the binary output case.
3.4. Spatio-temporal colormap
It is well known that seizures evolve both temporally and spatially.
The spatial component is not included with the previous two methods.
Although it is possible to generate 8 probabilistic traces from ‘Smoothed
probability of seizure per channel’ in Fig. 2, it would be difﬁcult to
display them compactly and intuitively for healthcare professionals. A
colormap to convey this information is proposed as seen in Fig. 3(d).
The colormap is designed to range from cold blue (probability 0) to
warm red (probability 1) though neutral white (probability 0.5). In
total, 10 different colours are used to simplify the interpretation.
The colormap allows the observation of both temporal and spatial
contexts of the conﬁdence output of the system. Thus, the information
content is the highest among the discussedmethods. The interpretation
becomes difﬁcult and the clinical personnel will need to be pre-trained
to be able to correctly interpret the colormap.
3.5. Audiﬁed neonatal EEG
It is believed that human hearing input is better than the visual input
when it comes to assessing both the spatial and temporal evolution ofthe frequency characteristics of a signal. Hearing is ﬂexible, low-cost
and fast and there are a range of available algorithms that can synthe-
size the sound from data in order to make speciﬁc features within the
data perceptible. Soniﬁcation or auditory display of signals naturally
extends visualization.
Human EEG has previously been audiﬁed for the purpose of the
detection of epilepsy in adults in [37,38]. In this work, neonatal EEG is
audiﬁed to assess its usefulness for the detection of neonatal seizures.
The process is outlined in Fig. 4 with an example of 1000 s of EEG as
an input. First, the same pre-processing steps are applied to EEG as in
the seizure detector. Then, the EEG is passed through the phase vocoder
[39,40] to change the temporal characteristics of the signal while
retaining its short-time spectral characteristics. This process intuitively
corresponds to stretching the time-base of a signal spectrogram. The
signal sampled with 32 Hz is thus slowed down by a factor of 100 by
the phase vocoder. It is then saved with 32 kHz sampling frequency.
This corresponds to the frequency mapping of the original range of
0.5–13 Hz to the new range of 0.5–13 kHz so that the most dominant
frequencies of seizure 0.5–6Hz aremapped to themost sensible audible
range, in particular to the range of human scream 3–4 kHz. The EEG
audiﬁcation technique allows for speeding up the EEG real-time play-
back, in our case by a factor of 10 allowing 1 h of EEG to be played in
roughly 6 min.
The resultant audio signal is made stereo, with left/right channels
corresponding to left/right brain hemispheres. In contrast to EEG
audiﬁcation in [37,38], the automated seizure detection algorithm is
used here to select a channel from each hemisphere with the highest
cumulative seizure probability. Moreover, the signal gain is controlled
by the probabilistic output of the system, thus accentuating suspicious
EEG segments.
4. Visualization and metrics
A fewmetrics are commonly used to quantify the performance of the
neonatal seizure detector. Themetrics canbe based onpatients (whether
a patient had at least one seizure or none), events (seizure events or false
detections) and epochs (seizure burden). For instance, sensitivity can
refer to the accuracy of detecting seizure patients, accuracy of detecting
seizure events or temporal precision of detected seizure onsets and off-
sets. The competingmetric is speciﬁcity or 1—speciﬁcitywhichmeasures
the rate of false detections such as falsely detected seizure patients, the
number of false seizure detections per hour or the amount of falsely
detected seizure activity in time. Several differences in how thesemetrics
should be computed for online, in contrast to ofﬂine systems, for seizure
detection have been addressed in [41]. In this section, the connection
between the computed metrics and the system output visualization is
established.
Consider a choice of N threshold values such that θi ∈ {θ1,…, θN}. If
there are M testing patients in the dataset, then a speciﬁcity matrix
SP= (SPij) ∈ RN × M and sensitivity matrix SE= (SEij) ∈ RN × M can be
produced where SPij (SEij) is the speciﬁcity (sensitivity) results for the
jth patient with the threshold choice θi. The ﬁnal metric (AUC) can be
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each patient independently (for instance, using an average of a number
of trapezoidal approximations) and then averaged across patients:
AUC ¼ 1
M
XM
j¼1
XN
i¼2
SPi; j−SPi−1; j
  SEi; j þ SEi−1; j
 
2
: ð1Þ
Alternatively, speciﬁcity and sensitivity values can ﬁrst be averaged
across patients and then the ﬁnal AUC is computed as:
AUC ¼
XN
i¼2
SPi−SPi−1
  SEi þ SEi−1
 
2
ð2Þ
where
SEi ¼
1
M
XM
j¼1
SEi; j; SPi ¼
1
M
XM
j¼1
SPi; j: ð3Þ
With the latter method, the reported performance is meaningful
only if the system output is visualized in the binary form. This happens
because the sensitivity and speciﬁcity values are threshold-wise aver-
aged across patients (Eq. (3)). Thus, the ﬁnal AUC summarises the per-
formance that the systemwill achieve with a particular threshold for all
patients. Therefore, if the system is designed to output binary values, the
correct way to report the performance of such a system is by averaging
its sensitivity and speciﬁcity across patients before computing the AUC.
In contrast the calculation of the AUC for each patient separately and
averaging them, summarises not the performance of the system for a
particular threshold for all patients but rather a discriminability of the
probabilistic output of the seizure detection system for each patient
which is averaged across all patients.
Fig. 5 shows an example of the probabilistic output for 2 patients for
15-minute EEG segments. In both cases, an increase in the probability
was seen for a seizure event. Although, both probabilistic traces show
perceivable difference between the probabilistic levels for seizure and
non-seizure, it is obvious that the AUC computed by averaging the sen-
sitivity and speciﬁcity over a set of common ﬁxed thresholds across the
two patients will be lower than the average of the AUCs computed for
each patient independently. Hence, if the system output is supposed
to be visualized using the probabilistic trace (or the colormap), the
correct way to report the performance of such a system is to compute
the AUC from each patient and then average.Patient 1 
0
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0.4
0.6
0.8
1
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25:12:45 25:19:45
Fig. 5. An example of the probabilistic output of the system for two ﬁfteen-minute EE5. Survey results and discussion
To determine the most suitable, convenient and synergetic way to
visualize the output of the developed seizure detector in a clinical
environment, a survey of the clinical personnel from the NICU of Cork
University Maternity Hospital was performed and is reported in this
study. Fourteen people participated in the survey. Among them there
were 5 neonatologists with experience in interpreting EEG. They direct-
ly represent potential end users of the DSS. Their opinions are the most
valuable for the scope of the study and are presented here.
The survey was organized as follows. Eleven 1 h 8-channel EEG
segments were selected from the database of continuous neonatal EEG
[19,21]. For each EEG segment, 4 slides were made as shown in the
example in Fig. 6. The ﬁrst slide is aEEG only which represents current
clinical practice. The other slides show a combination of the current
clinical practice with the output of the DSS; aEEG + binary, aEEG +
probabilistic, and aEEG + spatio-temporal colormap. In total, 44 slides
were created. Two examples, one with no seizures and the other with
a single clear 5-minute-long seizure in the middle, were used for
quick training purposes. This is done in order to explain to the surveyed
audience how the output of the classiﬁer typically looks for seizure and
background EEG in the formof binary, probabilistic and spatio-temporal
colormap output. The remaining 9 examples formed 36 slides which
were proposed to the audience. The order of slides was randomised to
eliminate possible effects of learning during survey. It was assured
that the audience could not change their previous decisions, e.g. when
accidentally the more informative system output such as the colormap
followed the binary output for the same example. The audience was
instructed that some examples may contain no seizures.
For every slide, the audience was asked 3 questions: 1) ‘Is there a
seizure in the recording?’ 2) ‘How many seizures are there?’, and
3) ‘Provide time onset and offset of every detected seizure’. These
questions target 3 levels of metrics: patient based, event-based and
epoch-base as discussed in Section 4. The ﬁrst question intends to cap-
ture whether a baby with at least one seizure has been missed. The
second one identiﬁes whether or not all of the seizures were caught.
The third question allows for computation of the number of false
seizures detected and the temporal accuracy of the detected seizure.
At the end of the survey, the audience was asked which visualization
technique was found more appropriate, useful, or convenient. In total,
the audience was asked 109 questions (36 ∗ 3 + 1).
For EEG audiﬁcation, a similar survey was performed online where
the audiﬁed EEG output was accompanied with the corresponding
aEEG traces. The audience was given the same 11 EEG segments (2 for
training and 9 for testing) which were 6 min of audio per an hour of
EEG. All examples of audiﬁed neonatal EEG used in the survey can be
found online, http://rennes.ucc.ie/~andreyt/visual/. Neither neonatal
clinicians nor other surveyed users had any experience in listening toPatient 2
13:27:12 13:34:12 Time
G segments from 2 patients. Clinical annotations are superimposed on top in red.
(a)
F4–C4 aEEG
F3–C3 aEEG
(b)
F4–C4 aEEG
F3–C3 aEEG
Threshold outputF4–C4 aEEG (6cm/h) F3–C3 aEEG (6cm/h)
(c)
F4–C4 aEEG
F3–C3 aEEG
Probability output
(d)
F4–C4 aEEG
F3–C3 aEEG
Spatio-temporal colormap
Fig. 6. An example of the 4 slides made for each of the 9 test examples, (a) aEEG alone, (b) aEEG + binary, (c) aEEG + probabilistic, and (d) aEEG + spatio-temporal colormap.
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Fig. 7. The results of the survey.
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For this reason, the results of audiﬁed EEG presented here are obtained
from the surveyed audience including non-healthcare professionals.
With respect to the ﬁrst two questions of the survey, aEEG and the 3
visualization methods each provided 100% accuracy in identiﬁcation of
the non-seizure examples. With regards to the seizure examples, the
audience using aEEG alone identiﬁed only 67% of recordings with at
least 1 seizure. It is slightly higher than the sensitivity reported in the lit-
erature. For instance, in [43] using aEEG 57% of the seizure-containing
records were detected with no false-positive seizure detections in
control records. The performance of aEEG greatly depends on the expe-
rience of the user and may vary signiﬁcantly. Importantly, all 3 visuali-
zation methods increased the ability of a clinician to identify whether
a given segment contained at least 1 seizure with 80%, 92%, and 88%
accuracy, for binary, probabilistic and colormap, respectively.
The answers to question 3 of the survey are summarised in Fig. 7 for
the epoch-based sensitivity and speciﬁcity metrics. The ‘Sys Prob’ curve
(probabilistic systemoutput) and the ‘Sys Bin’ point (binary systemout-
put) indicate the performance of the system itself on the chosen exam-
ples. The other points, ‘Clin aEEG’, ‘Clin aEEG+ Bin’, ‘Clin aEEG+ Prob’,
‘Clin aEEG + Color’, and ‘Clin aEEG + Aud’ indicate the performance
achieved by the surveyed audience using aEEG alone, aEEG + binary,
aEEG + probabilistic, aEEG + spatio-temporal colormap, and aEEG +
audiﬁed EEG, respectively.It can be seen that the performance achieved with aEEG alone con-
forms towhat has beenpreviously reported. Sensitivity of 38% and spec-
iﬁcity of 92% using aEEGwere reported in [5]. Sensitivity of 12%–38% has
92 A. Temko et al. / Decision Support Systems 70 (2015) 86–96been reported in [43]. It can be seen from Fig. 7 that all three visual
methods increased the performance of a conventional aEEG diagnosis.
The colormap resulted in the highest speciﬁcity and the probability
method resulted in the highest sensitivity. If the audience had absolute
conﬁdence in the system, then of course, all three points would be on
the curve. On the contrary, the results of the visualization methods lie
between the results of using aEEG alone and the system performance
curve. This indicates that clinicians by default trust aEEG and it would
take time for them to gain conﬁdence in the algorithm, regardless of
which visualization method is eventually selected. Interestingly, the
binary output is slightly closer to the colormap than to the probabilistic
output.
It can also be observed from Fig. 7 that the results of using audiﬁed
EEG are separated fromall othermethods. It has been observed that cer-
tain seizuremorphologies resulted in a very distinct high pitched sound.
This technique provided the second lowest sensitivity which indicates
that not all seizures resulted in this sound. However, this clearly audible
high pitched phenomenon was seen to be solely speciﬁc to seizures as
indicated by its speciﬁcity which is by far the largest among all the
considered methods.
It is worth noting that the location of the points which resulted from
the survey should be compared to each other rather than to the system
performance curve. The curve of system performance per se depends on
the complexity of the 9 chosen examples. In this study, the performance
equals to 98% of AUC, which is larger than the AUC of 95–97% previously
reported for the same system [20,34]. This left little space for the
surveyed audience to improve over the system results.
The results of visualization methods along with the system valida-
tion results indicate that the developed neonatal seizure detector with
its current level of performance would unambiguously be of beneﬁt to
clinicians as a DSS and will increase the neonatal seizure detection rate.
6. The interface of the DSS for the clinical trial
Answering the very last question of the survey, 3 out of 5 clinicians
named the binary system output to be the most convenient. As
discussed in Section 3, the binary output needs a threshold to be
deﬁned. For this reason, the dependency of the system performance
on the threshold selectionwas investigated. The twometrics considered
were the good detection rate which is the percentage of correctly
detected seizures and the number of false detections per hour. The0.4 0.5 0.6
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
Thresho
M
et
ric
 va
lu
es G
Fig. 8. Threshold seformer deﬁnes the event sensitivity of the algorithm and the latter indi-
cates the cost. Fig. 8 shows how both the good detection rate and the
number of false detections per hour decrease by increasing the thresh-
old on seizure probability. It should be noted that Fig. 8 plots the average
seizure detection rate and the upper bound of the 95% conﬁdence inter-
val of the number of false detections per hour. As such the performance
in Fig. 8 is over-pessimistic, as it displays the regular beneﬁts at the
worst-case-scenario cost. It can be seen from Fig. 8 that the system
can detect 50% of seizures with a cost bounded by 1 false alarm every
10 h (threshold = 0.65). Alternatively, 30% of seizures can be detected
with a cost bounded by 1 false alarm every 100 h (threshold = 0.95)
or at a cost of 1 false alarm every 5 h, the system can detect 60% of sei-
zures. From Fig. 8 a threshold of 0.5 was agreed to be ﬁxed throughout
the clinical trial.
Fig. 9 (top) shows the interface of the DSS which is currently under-
going pre-market European multi-centre clinical investigation to
support its regulatory approval and clinical adoption (the ANSeR
study—Algorithm for Neonatal Seizure Recognition http://clinicaltrials.
gov/show/NCT02160171). The output of the decision support tool was
chosen to be a combination of the binary and probabilistic outputs of
the classiﬁer. The upper most trace displays the probabilistic output
which is plotted in blue when it is below the threshold and in red
when it surpasses the threshold and complies with the artefact detector
[33]. Below this, the tool also shows 2 channels of aEEG. The tool allows
for clicking on the probabilistic trace or the aEEG trace, inwhich case the
review pane is opened as shown in Fig. 9 (bottom). The time indicator
shows the chosen time-point for reviewing. The multi-channel EEG
activity that corresponds to that time point as indicated by the green
brace is displayed. This interface has been agreed by the participants
of the clinical trial which represent 8 maternity hospitals around
Europe.
Fig. 10 shows the architecture of the DSS in a clinical environment.
The software system requires the EEG acquisition system for operation.
TheDSS is installed on a laptop connected to the EEG acquisition system.
7. Relation to the theory of decision support system
A clinical DSS is deﬁned as interactive computer software which is
designed to assist healthcare professionals in the decision making pro-
cess [49,57]. There exist a number of taxonomies that can describe a
given DSS [50]. The system presented in this work is an active intelligent0.7 0.8 0.9 1
ld values
ood detection rate
False detection per hour
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Fig. 9. Top: The real-time interface of the decision support system for the clinical trial. Bottom: The review mode.
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using elements of artiﬁcial intelligence.
Although clinical DSS have showngreat promise in reducingmedical
errors and improving patient care they donot always result in improved
clinical practice, for reasons that are not always clear. The importance of
rigorous and adaptive clinical DSS design to bridge the gap between
academic research and clinical practice using technology acceptance
models has been discussed in [53]. The concepts of acceptance behav-
iour formation and actual system use were incorporated into the
existing technology acceptance model. The model of uniﬁed theory of
acceptance and use of technology has also been used in [54]. The strat-
egies to facilitate more widespread technology adoption were identi-
ﬁed. The main factors that inﬂuence DSS acceptance and use were the
DSS usefulness, trust in the knowledge base, presentation of informa-
tion, ease of use and facilitating conditions (workﬂow integration).
The key experiences from previous efforts to design and implement
clinical DSS have also been summarised in [58]. The quality and timeli-
ness of information provided by the developed DSS have been tackled
by the rigorous technical validation [19,33] and will be addressed in
further studies of the group in the evidence from the clinical trial.It is true that the pathway to clinical adoption of any DSS is partly
hindered by the unnecessary workﬂow disruptions introduced [57].
The importance of integrating a newly developed DSS into the
established clinical workﬂow has been stressed in many studies [49,
51]. Analysis of 70 randomised controlled trials reported in [52] has con-
cluded that an effective clinical DSS must minimise the effort required
by clinicians to receive and act on system recommendations. Given
that the demand on staff time is high, the DSS must become a ﬂuid
and integral part of theworkﬂow. In thiswork the developedDSS is pre-
sented on the laptop along with the current clinical practice monitors.
This decision was driven by the regulatory constraints. Ultimately, the
DSS system will be incorporated into the EEG software system. The
clinician does not have to stop working on the existing information
systems in order to access the DSS recommendations. Additionally, the
data are fed to the developed software from the same recording device
so that the information provided by the current clinical practice and the
DSS recommendations are synchronised in time.
The remaining concepts to be addressed are the ease of use and
presentation of information of the DSS. The ‘ﬁve rights’ of the clinical
DSS are known as right information to the right people through the
DECISION SUPPORT TOOL
HOSPITAL LAPTOP
EEG MACHINE
Fig. 10. Decision support tool architecture.
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the key questions are those whose decisions are being supported, what
information is presented, when it is presented and how it is presented
[57]. The form that the information is presented in may potentially con-
vert an important DSS to an unusable and redundant piece of software.
Information visualization aims to achieve several goals such as intuitive
data formatting, emphasising subtle aspects of reasoning, or to prevent
information overload. The latter, the problem of very dense display of
data in the context of intensive cares units while monitoring patients
with severe brain injury has been addressed in [55] including temporal
data abstraction, principal component analysis, and clusteringmethods.
A number of intelligent information visualization methods have
been surveyed in [56]. A categorization scheme was developed based
on representation criteria such as 2D vs 3D, static vs dynamic, with
the application to time-series analysis. Recent works on the intelligent
visualization and interpretation of clinical data have been reviewed in
[61]. Information visualization is closely related to the decision making
biases. It has been argued that error management theory may explain
the evolution of cognitive and behavioural biases in human decision
making under uncertainty [59]. Traditional and novel technology-
mediated medical decision making approaches have been critically ex-
amined in [60]. This study quantitatively and qualitatively addresses
the problem of information representation. Information provided by
the DSS extends natural human cognitive limitations by using visual
and auditory systems. In this manner, the load imposed by information
gathering goals can be alleviated to allocate more cognitive resources
for discriminating among hypothesis and making complex decisions
[60].
8. Healthcare beneﬁts
The transformation of neonatal care over the last 20 years has result-
ed in extremely premature and very ill babies having a better chance of
survival than ever before. However it is still difﬁcult to predict which
babieswill die andwhichwill survivewith severe disabilities. The social
consequences and lifelong economic costs resulting fromneonatal brain
injury are extremely high. The challenge for modern medicine is to
reduce the disability rate by understanding which factors cause these
problems, how to detect and treat them early and how to prevent
them. Neonatal seizures are a common emergency in intensive care,
occurring in about 1–3 per 1000 babies born at term (they are more
common in pretermbabies, [45]). To put this in perspective, the numberof births in Ireland is approximately 75,000 per year, in the UK, 700,000
and worldwide there are approximately 131 million births each year.
Hypoxic ischaemic encephalopathy as a result of perinatal asphyxia
is the commonest cause of seizures in neonates and represents a very
signiﬁcant health-care and ﬁnancial burden. Globally, this is a much
larger problem with 23% of the 4 million neonatal deaths worldwide
being due to perinatal asphyxia [46]. The risk of permanent neurological
injury causing lifelong disability after HIE complicated by seizures is
high, and the costs of care for disabled survivors is usually several mil-
lion dollars. NICU costs in the UK are estimated at over $2000 per day,
with an average duration of admission of 10 days. Estimated costs of
disabled children range from $30,000–$120,000 yearly for moderately
and severely disabled children respectively. The disability experienced
by survivors includes cerebral palsy, epilepsy and learning difﬁculties
[47]. The quality of life of the childwith profound neurological handicap
is very poor. The amount of care which disabled children require has
implications for parents, siblings and the health service. Improvement
of neurodevelopmental outcome could have a dramatic impact on
these children and their families.
On the other hand, over-treatment of babieswith antiepileptic drugs
carries the risk of using neurotoxic medications, prolonging intensive
care (with associated costs and parental separation) and increases the
risk of complications. The current clinical standard of care is to treat
babies based solely on clinical diagnosis of seizures (physical manifesta-
tions). EEG studies carried out by ourselves and others have shown this
to be inaccurate and unreliable and to lack any evidence base [48].
Increasingly, clinicians are using cot-side aEEG to guide their therapy
but surveys show that interpretation skills are limited, and this method
does not reliably detect all seizures [3]. Clinicians caring for babies af-
fected by seizures are poorly supported by specialist neurophysiology,
which is a scarce resource, and would embrace and welcome an intelli-
gent cot-side decision support tool. A robust, reliable, automated seizure
detection system which is easy to use and interpret would be widely
welcomed. Such a system would ensure prompt recognition of ‘true’
seizures and facilitate individual tailoring of antiepileptic drug treat-
ment, avoiding prolonged multi-drug regimens. This should improve
neurodevelopmental outcome and reduce intensive care days. In addi-
tion, babies with jittery movement patterns which are not epileptic
would quickly be recognised as ‘non-seizure’ and would avoid invasive
investigations, separation from their parents, and unnecessary intensive
care admissions involving treatment with potentially toxic drugs.9. Future work
The developed neonatal seizure detection algorithmwill be the ﬁrst
to be tested in a randomised clinical trial. There are a number of trial
outcomes that will have to be further analysed and will form part of
our future work.
Previous studies in the area have discussed a number of different
metrics which are summarised in Section 4. These metrics range from
purely engineering, signal processing and machine learning perspec-
tives to more clinical viewpoints. However, the evaluation setup and
metrics have implicitly considered an ‘ofﬂine’ scenario. In contrast, the
‘online’ scenario, that is running a tool not retrospectively but in a real
clinical setting, may have different milestones. To date there has been
little work done on connecting the reported metrics to real-life effects.
The improvement of the neurodevelopmental outcome of the babies is
a ﬁnal targetwhich has a number of constituents; for instance, the num-
ber of antiepileptic drugs given correctly or in vain, time points of these
drugs relative to the onset of seizures, etc. These metrics will be back
traced to the originalmathematical formulations of the decision support
system and may result in a number of important changes. For instance,
itmay be beneﬁcial to have a higher conﬁdencewhendetecting the very
ﬁrst seizure or detection of longer seizures may be prioritised. These
open questions will have to be answered.
95A. Temko et al. / Decision Support Systems 70 (2015) 86–96The level of agreement between the annotations (inter-observer
agreement) and the neonatal seizure detection algorithm will be also
assessed using a variety of measures. It will allow for comparison of
the level of accuracy of the algorithm with that of human expert error.
10. Conclusions
Three different visualization methods to convey information from
the developed neonatal seizure detection system have been presented,
discussed and contrasted. Their relation to the metric computation
methods has been established. The algorithm-driven audiﬁcation of
neonatal EEG has also been explored as an alternative to visual aids. A
survey of the targeted end users was made in order to determine
the level of optimality of each of the proposed methods. It has been
shown that all methods have the potential to improve the performance
of neonatal seizure detection in a clinical environment over the conven-
tional aEEG approach.Without any dedicated training of clinical person-
nel, the binary visualization form was preferable. The survey results
have assisted in the deﬁnition of the decision support tool interface.
The decision support tool with the chosen visualization interface is
currently undergoing pre-market European multi-centre clinical inves-
tigation to support its regulatory approval and clinical adoption.
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